Bio-Techne Corporation
TECH
$72.25
-$0.06-0.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 181.86M | 109.56M | 81.10M | 77.99M | 73.40M |
| Total Depreciation and Amortization | 59.56M | 56.33M | 59.73M | 62.11M | 65.90M |
| Total Amortization of Deferred Charges | 37.80M | 44.00M | 44.00M | 44.00M | 44.00M |
| Total Other Non-Cash Items | 54.16M | 108.51M | 96.40M | 88.73M | 92.71M |
| Change in Net Operating Assets | -41.30M | -23.55M | -31.92M | -21.57M | 11.54M |
| Cash from Operations | 292.07M | 294.86M | 249.32M | 251.25M | 287.56M |
| Capital Expenditure | -28.85M | -25.26M | -26.30M | -27.20M | -31.01M |
| Sale of Property, Plant, and Equipment | 4.62M | 5.28M | 5.28M | 7.06M | 2.45M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.04M | 9.26M | 7.24M | 7.24M | -6.62M |
| Cash from Investing | -18.19M | -10.73M | -13.78M | -12.89M | -35.18M |
| Total Debt Issued | -- | 66.00M | 104.00M | 104.00M | 104.00M |
| Total Debt Repaid | -146.00M | -196.00M | -144.00M | -104.00M | -77.00M |
| Issuance of Common Stock | 80.62M | 64.42M | 49.33M | 50.13M | 51.74M |
| Repurchase of Common Stock | -53.82M | -110.96M | -211.14M | -286.52M | -282.25M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -49.92M | -49.82M | -49.88M | -50.15M | -50.39M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -169.11M | -226.36M | -251.69M | -286.54M | -253.91M |
| Foreign Exchange rate Adjustments | -2.24M | 11.38M | 11.48M | 5.60M | 11.93M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.53M | 69.15M | -4.67M | -42.58M | 10.40M |